# The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024, Regulation 3: Amendment to regulation 2 (interpretation)


In regulation 2(1)—
(a) for the definition of “relevant essential requirements” substitute—
““relevant essential requirements”—
(a) in Part 4A, has the meaning given in regulation 44ZC;
(b) in all other Parts, in relation to a medical device, means the essential requirements set out in Annex 1 of Directive 90/385, Annex I of Directive 93/42 or Annex I of Directive 98/79 which apply to it, but not including, in the case of a device intended for clinical investigation, such of those requirements, or aspects of them, as are the subject of the investigation;”;
(b) for the definition of “Regulation (EU) No 722/2012” substitute—
““Regulation (EU) No 722/2012”—
(a) in Part 4A, has the meaning given in regulation 44ZC;
(b) in all other Parts means Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin (as retained under section 3 of the European Union (Withdrawal) Act 2018 and modified under section 8 of that Act);”;
(c) after the definition of “UK responsible person” insert—
““working day” means any day which is not Saturday, Sunday, Christmas Day, Good Friday or a day which is a bank holiday in any part of Great Britain under the Banking and Financial Dealings Act 1971.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348264593/regulation/3 (the official version)
Page: https://openlegislation.uk/draft-medical-devices-post-market-surveillance-requirements-amendment-great-britain-regulations-2024/regulation-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.